(1R,3S)-5-[2-[9-(3-Hydroxy-3-methyl-butoxy)-spiro[5.5]undec-(2Z)-ylidene]-eth-(E)-ylidene]-4-methylene-cyclohexane-1,3-diol

ID: ALA3085006

Chembl Id: CHEMBL3085006

PubChem CID: 44392872

Max Phase: Preclinical

Molecular Formula: C25H40O4

Molecular Weight: 404.59

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1/C(=C/C=C2/CCC[C@]3(CC[C@H](OCCC(C)(C)O)CC3)C2)C[C@@H](O)C[C@@H]1O

Standard InChI:  InChI=1S/C25H40O4/c1-18-20(15-21(26)16-23(18)27)7-6-19-5-4-10-25(17-19)11-8-22(9-12-25)29-14-13-24(2,3)28/h6-7,21-23,26-28H,1,4-5,8-17H2,2-3H3/b19-6-,20-7+/t21-,22-,23+,25+/m1/s1

Standard InChI Key:  UQSARBUPJSZNBU-OQBCDAHPSA-N

Associated Targets(Human)

VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

VDR Vitamin D3 receptor (135 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vdr Vitamin D receptor (250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.59Molecular Weight (Monoisotopic): 404.2927AlogP: 4.59#Rotatable Bonds: 5
Polar Surface Area: 69.92Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.66CX LogD: 2.66
Aromatic Rings: Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: 1.71

References

1. Schepens W, Van Haver DV, Vandewalle M, De Clercq PJ, Bouillon R, Verstuyf A..  (2004)  Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues.,  14  (15): [PMID:15225691] [10.1016/j.bmcl.2004.05.058]

Source